Cannabidiol (CBD), a non-psychoactive compound found in cannabis, is gaining attention for its potential to alleviate symptoms of ulcerative colitis (UC), a chronic inflammatory bowel disease. Some studies suggest CBD may help reduce inflammation and improve quality of life for UC patients, though the evidence remains inconclusive.

Keith Sharkey, Ph.D., from the University of Calgary, notes that the relationship between CBD and UC is complex, with limited high-quality research available. While some patients report symptom relief, Sharkey emphasizes that CBD is not a substitute for conventional treatments.

A 2021 study found that THC-rich cannabis induced clinical remission in some UC patients but did not significantly reduce inflammation. Another review highlighted potential risks, including adverse effects and complications during pregnancy.

For those considering CBD for UC, consulting with a healthcare provider is crucial. More research is needed to fully understand its benefits and risks. For more details, visit the original article on HealthCentral here.